首页 > 最新文献

Annals of Internal Medicine最新文献

英文 中文
Proteinuria or Albuminuria as Markers of Kidney and Cardiovascular Disease Risk : An Individual Patient-Level Meta-analysis. 蛋白尿或蛋白尿作为肾脏和心血管疾病风险的标志物:个体患者水平的荟萃分析
IF 15.2 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 Epub Date: 2025-11-04 DOI: 10.7326/ANNALS-25-02117
Hiddo J L Heerspink, Morgan E Grams, Yingying Sang, Shoshana H Ballew, Josef Coresh, Aditya Surapaneni, Natalia Alencar de Pinho, Nigel J Brunskill, Alexander R Chang, Elizabeth Ciemins, Laura M Dember, Keiko Kabasawa, Lindsey Kornowske, Adeera Levin, Rupert Major, Patrick B Mark, Eric McArthur, James Medcalf, Marie Metzger, Girish N Nadkarni, David M J Naimark, Cassianne Robinson-Cohen, Keiichi Sumida, Robin W M Vernooij, Ron T Gansevoort, Bengt Fellström, Steven Chadban

Background: Urinary albumin-creatinine ratio (UACR) and urinary protein-creatinine ratio (UPCR) are both used in clinical practice to diagnose and monitor chronic kidney disease (CKD). Which measure exhibits stronger associations with clinical outcomes and whether this varies by patient characteristics are unknown.

Objective: To assess and compare the performance of UACR and UPCR across CKD-related clinical outcomes.

Design: Individual patient-level meta-analysis.

Setting: 38 research and clinical cohorts.

Participants: 148 994 participants with same-day measurements of UACR and UPCR.

Measurements: We quantified the associations of UACR and UPCR with subsequent clinical outcomes, including kidney failure and cardiovascular events, using Cox proportional hazards regression. Analyses were done in each cohort, followed by random-effects meta-analysis. Subgroups included those based on severity of proteinuria, type 2 diabetes, estimated glomerular filtration rate (eGFR) less than 60 mL/min/1.73 m2, and glomerular disease.

Results: There were 148 994 participants and 9773 kidney failure events during a median of 3.8 years of follow-up. Higher UACR and UPCR both had a log-linear association with increased risk for kidney failure. The association with kidney failure was somewhat stronger for UACR (adjusted hazard ratio [HR] per SD increment, 2.55 [95% CI, 2.36 to 2.74]) than UPCR (HR, 2.40 [CI, 2.28 to 2.53]; P for comparison<0.001). Results were consistent to slightly stronger in subgroups with UACR greater than 30 mg/g, UPCR greater than 500 mg/g, eGFR less than 60 mL/min/1.73 m2, diabetes, and glomerular disease. Associations between UACR and UPCR were generally similar for cardiovascular outcomes but favored UACR in subgroups with moderately to severely elevated UACR.

Limitation: Assessment of UACR and UPCR in spot urine samples.

Conclusion: Overall, UACR was more strongly associated with kidney failure than UPCR (particularly in subgroups with higher UACR), supporting the use of UACR rather than UPCR to diagnose and risk-stratify patients.

Primary funding source: National Kidney Foundation and National Institute of Diabetes and Digestive and Kidney Diseases.

背景:尿白蛋白-肌酐比值(UACR)和尿蛋白-肌酐比值(UPCR)均用于临床诊断和监测慢性肾脏疾病(CKD)。哪一种测量方法与临床结果的相关性更强,以及这种相关性是否因患者特征而异,目前尚不清楚。目的:评估和比较UACR和UPCR在ckd相关临床结果中的表现。设计:个体患者水平荟萃分析。环境:38个研究和临床队列。参与者:1448994名参与者,当天测量UACR和UPCR。测量:我们量化了UACR和UPCR与后续临床结果的关联,包括肾衰竭和心血管事件,使用Cox比例风险回归。对每个队列进行分析,然后进行随机效应荟萃分析。亚组包括蛋白尿、2型糖尿病、估计肾小球滤过率(eGFR)小于60 mL/min/1.73 m2和肾小球疾病的严重程度。结果:在中位3.8年的随访期间,共有144894名参与者和9773例肾衰竭事件。较高的UACR和UPCR均与肾衰竭风险增加呈对数线性相关。UACR与肾衰竭的相关性(每SD增量调整后的危险比[HR], 2.55 [95% CI, 2.36至2.74])比UPCR (HR, 2.40 [CI, 2.28至2.53])更强;P为比较2、糖尿病和肾小球疾病。UACR和UPCR在心血管预后方面的相关性大致相似,但在UACR中度至重度升高的亚组中,UACR更受青睐。局限性:评估UACR和UPCR在现场尿样。结论:总体而言,与UPCR相比,UACR与肾衰竭的相关性更强(特别是在UACR较高的亚组中),支持使用UACR而不是UPCR来诊断和风险分层患者。主要资金来源:国家肾脏基金会和国家糖尿病、消化和肾脏疾病研究所。
{"title":"Proteinuria or Albuminuria as Markers of Kidney and Cardiovascular Disease Risk : An Individual Patient-Level Meta-analysis.","authors":"Hiddo J L Heerspink, Morgan E Grams, Yingying Sang, Shoshana H Ballew, Josef Coresh, Aditya Surapaneni, Natalia Alencar de Pinho, Nigel J Brunskill, Alexander R Chang, Elizabeth Ciemins, Laura M Dember, Keiko Kabasawa, Lindsey Kornowske, Adeera Levin, Rupert Major, Patrick B Mark, Eric McArthur, James Medcalf, Marie Metzger, Girish N Nadkarni, David M J Naimark, Cassianne Robinson-Cohen, Keiichi Sumida, Robin W M Vernooij, Ron T Gansevoort, Bengt Fellström, Steven Chadban","doi":"10.7326/ANNALS-25-02117","DOIUrl":"10.7326/ANNALS-25-02117","url":null,"abstract":"<p><strong>Background: </strong>Urinary albumin-creatinine ratio (UACR) and urinary protein-creatinine ratio (UPCR) are both used in clinical practice to diagnose and monitor chronic kidney disease (CKD). Which measure exhibits stronger associations with clinical outcomes and whether this varies by patient characteristics are unknown.</p><p><strong>Objective: </strong>To assess and compare the performance of UACR and UPCR across CKD-related clinical outcomes.</p><p><strong>Design: </strong>Individual patient-level meta-analysis.</p><p><strong>Setting: </strong>38 research and clinical cohorts.</p><p><strong>Participants: </strong>148 994 participants with same-day measurements of UACR and UPCR.</p><p><strong>Measurements: </strong>We quantified the associations of UACR and UPCR with subsequent clinical outcomes, including kidney failure and cardiovascular events, using Cox proportional hazards regression. Analyses were done in each cohort, followed by random-effects meta-analysis. Subgroups included those based on severity of proteinuria, type 2 diabetes, estimated glomerular filtration rate (eGFR) less than 60 mL/min/1.73 m<sup>2</sup>, and glomerular disease.</p><p><strong>Results: </strong>There were 148 994 participants and 9773 kidney failure events during a median of 3.8 years of follow-up. Higher UACR and UPCR both had a log-linear association with increased risk for kidney failure. The association with kidney failure was somewhat stronger for UACR (adjusted hazard ratio [HR] per SD increment, 2.55 [95% CI, 2.36 to 2.74]) than UPCR (HR, 2.40 [CI, 2.28 to 2.53]; <i>P</i> for comparison<0.001). Results were consistent to slightly stronger in subgroups with UACR greater than 30 mg/g, UPCR greater than 500 mg/g, eGFR less than 60 mL/min/1.73 m<sup>2</sup>, diabetes, and glomerular disease. Associations between UACR and UPCR were generally similar for cardiovascular outcomes but favored UACR in subgroups with moderately to severely elevated UACR.</p><p><strong>Limitation: </strong>Assessment of UACR and UPCR in spot urine samples.</p><p><strong>Conclusion: </strong>Overall, UACR was more strongly associated with kidney failure than UPCR (particularly in subgroups with higher UACR), supporting the use of UACR rather than UPCR to diagnose and risk-stratify patients.</p><p><strong>Primary funding source: </strong>National Kidney Foundation and National Institute of Diabetes and Digestive and Kidney Diseases.</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"32-41"},"PeriodicalIF":15.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12758604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145436970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interventions to Improve Advance Care Planning Documentation in the Electronic Health Record : A Cluster Randomized Trial. 改善电子健康记录中预先护理计划文件的干预措施:一项集群随机试验。
IF 15.2 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 Epub Date: 2025-11-25 DOI: 10.7326/ANNALS-25-02111
Anne M Walling, Rebecca L Sudore, Lisa Gibbs, Maryam Rahimi, Ron D Hays, Chi-Hong Tseng, Kanan Patel, Katherine Santos, Fernando Javier Sanz Vidorreta, Aaron J Chau, Juan Carlos Antonio Lopez, Jamie Anand, G Rick Marshall, Anna DePaolis-Dickey, Kirsten I Buen, Douglas S Bell, Christine S Ritchie, Victor Gonzalez, Neil S Wenger

Background: Advance care planning (ACP) can improve communication of patients' preferences but is underutilized in health systems.

Objective: To compare approaches to increase ACP.

Design: Pragmatic, 24-month, comparative, cluster randomized trial. (ClinicalTrials.gov: NCT04012749).

Setting: Fifty clinics in 3 University of California health systems.

Participants: All seriously ill primary care patients without an advance directive (AD) or a Physician Orders for Life-Sustaining Treatment (POLST) form in the electronic health record (EHR).

Intervention: Three ACP interventions, timed to primary care visits. The group 1 intervention included a letter with an AD sent via the EHR portal and mail. The interventions in groups 2 and 3 additionally included a link to PrepareForYourCare.org and a mailed pamphlet, and the group 3 intervention also included health navigator outreach. Clinicians received ACP training.

Measurements: Presence of AD or POLST form in the EHR at 12 and 24 months (primary outcome); documented ACP discussions and utilization (secondary outcomes).

Results: Among 5810 seriously ill patients (mean age, 71 years; 48% female; 50% in a racial or ethnic minority), by 24 months, 13.7% (95% CI, 12.1% to 15.3%) of patients in group 1, 12.7% (CI, 11.2% to 14.1%) in group 2, and 19.8% (CI, 18.1% to 21.5%) in group 3 had a documented AD or POLST form. After adjustment for patient and site factors, group 3 patients were more likely to have an AD or a POLST form compared with group 1 (adjusted difference [aDiff], 4.6% [CI, 0.8% to 8.4%]) and group 2 (aDiff, 5.5% [CI, 0.8% to 10.2%]); groups 1 and 2 did not differ significantly. Documented ACP discussions were higher in group 3 than group 1 (aDiff, 4.7% [CI, 1.4% to 7.9%]) and group 2 (aDiff, 4.2% [CI, 1.1% to 7.2%]); groups 1 and 2 did not differ. Utilization did not differ by group.

Limitations: Academic health centers; no control group.

Conclusion: Health system implementation of automated ACP interventions with clinician training and mailed materials increases ACP documentation and is enhanced with navigator outreach.

Primary funding source: Patient-Centered Outcomes Research Institute.

背景:预先护理计划(ACP)可以改善患者偏好的沟通,但在卫生系统中未得到充分利用。目的:比较提高ACP的方法。设计:实用的,24个月的,比较的,集群随机试验。(ClinicalTrials.gov: NCT04012749)。环境:加州大学3个卫生系统中的50个诊所。参与者:所有在电子健康记录(EHR)中没有预先指示(AD)或医生维持生命治疗(POLST)表单的重症初级保健患者。干预措施:三个ACP干预措施,定时到初级保健就诊。第一组干预包括一封带有广告的信件,通过电子病历门户和邮件发送。第二组和第三组的干预措施还包括一个PrepareForYourCare.org的链接和一个邮寄的小册子,第三组的干预措施还包括健康导航员外展。临床医生接受ACP培训。测量:12个月和24个月时EHR中AD或POLST形式的存在(主要结局);记录ACP的讨论和使用(次要结果)。结果:5810名重症患者(平均年龄71岁,48%为女性,50%为少数民族或种族),在24个月时,第1组13.7% (95% CI, 12.1% ~ 15.3%),第2组12.7% (CI, 11.2% ~ 14.1%),第3组19.8% (CI, 18.1% ~ 21.5%)的患者有AD或POLST形式的记录。在对患者和部位因素进行调整后,与1组(调整差值[aDiff], 4.6% [CI, 0.8%至8.4%])和2组(aDiff, 5.5% [CI, 0.8%至10.2%])相比,3组患者更容易发生AD或POLST形式;1、2组间差异无统计学意义。记录在案的ACP讨论3组高于1组(aDiff, 4.7% [CI, 1.4%至7.9%])和2组(aDiff, 4.2% [CI, 1.1%至7.2%]);1组和2组无差异。各组间的利用率无差异。限制:学术保健中心;没有对照组。结论:通过临床医生培训和邮寄材料,卫生系统实施自动化ACP干预增加了ACP文件记录,并随着导航员的推广而得到加强。主要资金来源:以患者为中心的结果研究所。
{"title":"Interventions to Improve Advance Care Planning Documentation in the Electronic Health Record : A Cluster Randomized Trial.","authors":"Anne M Walling, Rebecca L Sudore, Lisa Gibbs, Maryam Rahimi, Ron D Hays, Chi-Hong Tseng, Kanan Patel, Katherine Santos, Fernando Javier Sanz Vidorreta, Aaron J Chau, Juan Carlos Antonio Lopez, Jamie Anand, G Rick Marshall, Anna DePaolis-Dickey, Kirsten I Buen, Douglas S Bell, Christine S Ritchie, Victor Gonzalez, Neil S Wenger","doi":"10.7326/ANNALS-25-02111","DOIUrl":"10.7326/ANNALS-25-02111","url":null,"abstract":"<p><strong>Background: </strong>Advance care planning (ACP) can improve communication of patients' preferences but is underutilized in health systems.</p><p><strong>Objective: </strong>To compare approaches to increase ACP.</p><p><strong>Design: </strong>Pragmatic, 24-month, comparative, cluster randomized trial. (ClinicalTrials.gov: NCT04012749).</p><p><strong>Setting: </strong>Fifty clinics in 3 University of California health systems.</p><p><strong>Participants: </strong>All seriously ill primary care patients without an advance directive (AD) or a Physician Orders for Life-Sustaining Treatment (POLST) form in the electronic health record (EHR).</p><p><strong>Intervention: </strong>Three ACP interventions, timed to primary care visits. The group 1 intervention included a letter with an AD sent via the EHR portal and mail. The interventions in groups 2 and 3 additionally included a link to PrepareForYourCare.org and a mailed pamphlet, and the group 3 intervention also included health navigator outreach. Clinicians received ACP training.</p><p><strong>Measurements: </strong>Presence of AD or POLST form in the EHR at 12 and 24 months (primary outcome); documented ACP discussions and utilization (secondary outcomes).</p><p><strong>Results: </strong>Among 5810 seriously ill patients (mean age, 71 years; 48% female; 50% in a racial or ethnic minority), by 24 months, 13.7% (95% CI, 12.1% to 15.3%) of patients in group 1, 12.7% (CI, 11.2% to 14.1%) in group 2, and 19.8% (CI, 18.1% to 21.5%) in group 3 had a documented AD or POLST form. After adjustment for patient and site factors, group 3 patients were more likely to have an AD or a POLST form compared with group 1 (adjusted difference [aDiff], 4.6% [CI, 0.8% to 8.4%]) and group 2 (aDiff, 5.5% [CI, 0.8% to 10.2%]); groups 1 and 2 did not differ significantly. Documented ACP discussions were higher in group 3 than group 1 (aDiff, 4.7% [CI, 1.4% to 7.9%]) and group 2 (aDiff, 4.2% [CI, 1.1% to 7.2%]); groups 1 and 2 did not differ. Utilization did not differ by group.</p><p><strong>Limitations: </strong>Academic health centers; no control group.</p><p><strong>Conclusion: </strong>Health system implementation of automated ACP interventions with clinician training and mailed materials increases ACP documentation and is enhanced with navigator outreach.</p><p><strong>Primary funding source: </strong>Patient-Centered Outcomes Research Institute.</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"42-50"},"PeriodicalIF":15.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145595794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Q&A: Commercial cannabis linked to more ED visits. 问答:商业大麻与急诊科就诊人数增加有关。
IF 15.2 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 Epub Date: 2026-01-06 DOI: 10.7326/ANNALS-25-05215-IM
Gianna Melillo
{"title":"Q&A: Commercial cannabis linked to more ED visits.","authors":"Gianna Melillo","doi":"10.7326/ANNALS-25-05215-IM","DOIUrl":"10.7326/ANNALS-25-05215-IM","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"IMN5-IMN8"},"PeriodicalIF":15.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145905469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Polyps. 息肉。
IF 15.2 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.7326/ANNALS-25-01740
Yuki Teramoto
{"title":"The Polyps.","authors":"Yuki Teramoto","doi":"10.7326/ANNALS-25-01740","DOIUrl":"https://doi.org/10.7326/ANNALS-25-01740","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":"179 1","pages":"146"},"PeriodicalIF":15.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146002964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
My Nights Eat My Days: How My Eating Disorder Overshadowed the Autism No One Saw. 我的夜晚吞噬了我的白天:我的饮食失调如何掩盖了没有人看到的自闭症。
IF 15.2 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 DOI: 10.7326/ANNALS-25-03904
Whitney Voltz, Debra A Brown
{"title":"My Nights Eat My Days: How My Eating Disorder Overshadowed the Autism No One Saw.","authors":"Whitney Voltz, Debra A Brown","doi":"10.7326/ANNALS-25-03904","DOIUrl":"https://doi.org/10.7326/ANNALS-25-03904","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":"179 1","pages":"144-145"},"PeriodicalIF":15.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146003009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Individual-Level Interventions to Mitigate the Risk for Burnout Among Health Care Professionals : A Systematic Review and Meta-analysis of Randomized Controlled Trials. 个体水平干预措施减轻医护人员职业倦怠风险的有效性:随机对照试验的系统回顾和荟萃分析。
IF 15.2 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 Epub Date: 2025-11-18 DOI: 10.7326/ANNALS-25-00469
George Collett, Jaya Gupta, Abubaker Eltayeb, Ania Korszun, Linda Sharples, Kenneth Rice, Ajay K Gupta

Background: There is limited evidence of the strategies to mitigate burnout among all health care professionals (HCPs).

Purpose: To evaluate the effectiveness of all interventions to mitigate burnout among HCPs.

Data sources: PubMed and Scopus (up to 14 May 2025).

Study selection: Independent study selection (2 people) of randomized controlled trials (RCTs) and cluster RCTs of interventions to mitigate burnout (vs. no active intervention) among HCPs.

Data extraction: Independent extraction with validation by second reviewer. Continuous data for burnout outcomes extracted for emotional exhaustion (EE), depersonalization, personal accomplishment (PA), and single-concept burnout measurement. Separate random-effects models were stratified by role.

Data synthesis: 93 RCTs and 6 cluster RCTs evaluating individual-level interventions were included (9330 participants). Among physicians, professional coaching was probably effective in reducing some aspects of burnout (EE standardized mean difference [SMD], -0.37 [95% CI, -0.62 to -0.13], low certainty; and depersonalization SMD, -0.30 [CI, -0.42 to -0.19], moderate certainty), but mindfulness-based interventions may not be effective (EE SMD, -0.46 [CI, -1.28 to 0.35], very low certainty; depersonalization SMD, -0.09 [CI, -0.30 to 0.12], moderate certainty). However, mindfulness-based interventions may reduce burnout among nurses and midwives (EE SMD, -0.90 [CI,-1.46 to -0.34], low certainty) and among a mixture of HCP roles (EE SMD, -0.40 [-0.65 to -0.16], low certainty; depersonalization SMD, -0.36 [CI, -0.58 to -0.14], low certainty; and PA SMD, 0.48 [CI, 0.29 to 0.67], moderate certainty). Mindfulness-based and professional coaching interventions were generally more than 4 weeks in duration.

Limitations: Most trials were unblinded with subjective outcomes. There was substantial heterogeneity among interventions and populations despite stratifying by role.

Conclusion: Although mindfulness-based interventions may reduce burnout in nurses and midwives and among a mixture of HCPs, professional coaching probably reduces burnout among physicians, particularly when sustained for more than 4 weeks.

Primary funding source: Barts Charity. (PROSPERO: CRD42024552385).

背景:在所有卫生保健专业人员(HCPs)中减轻职业倦怠的策略证据有限。目的:评价所有干预措施减轻医护人员职业倦怠的有效性。数据来源:PubMed和Scopus(截至2025年5月14日)。研究选择:随机对照试验(rct)和集群rct的独立研究选择(2人),以减轻医护人员的职业倦怠(相对于无积极干预)。数据提取:独立提取,由第二审稿人验证。从情绪耗竭(EE)、人格解体(depersonalization)、个人成就(personal achievement)和单一概念倦怠测量中提取的倦怠结果的连续数据。单独的随机效应模型按角色分层。数据综合:纳入93项随机对照试验和6项评估个体水平干预措施的聚类随机对照试验(9330名参与者)。在医生中,专业指导可能在减少倦怠的某些方面有效(情感表达标准化平均差[SMD], -0.37 [95% CI, -0.62至-0.13],低确定性;人格解体SMD, -0.30 [CI, -0.42至-0.19],中等确定性),但基于正念的干预可能无效(情感表达SMD, -0.46 [CI, -1.28至0.35],非常低确定性;人格解体SMD, -0.09 [CI, -0.30至0.12],中等确定性)。然而,基于正念的干预可以减少护士和助产士的职业倦怠(EE SMD, -0.90 [CI,-1.46至-0.34],低确定性)和HCP角色的混合(EE SMD, -0.40[-0.65至-0.16],低确定性;去个性化SMD, -0.33 [CI, -0.53至-0.14],低确定性;PA SMD, 0.48 [CI, 0.29至0.67],中等确定性)。以正念为基础和专业教练干预的持续时间一般超过4周。局限性:大多数试验是非盲法的主观结果。尽管按角色分层,但干预措施和人群之间存在实质性的异质性。结论:虽然以正念为基础的干预可能会减少护士和助产士以及混合HCPs的职业倦怠,但专业指导可能会减少医生的职业倦怠,特别是当持续超过4周时。主要资金来源:巴茨慈善机构。(普洛斯彼罗:CRD42024552385)。
{"title":"Efficacy of Individual-Level Interventions to Mitigate the Risk for Burnout Among Health Care Professionals : A Systematic Review and Meta-analysis of Randomized Controlled Trials.","authors":"George Collett, Jaya Gupta, Abubaker Eltayeb, Ania Korszun, Linda Sharples, Kenneth Rice, Ajay K Gupta","doi":"10.7326/ANNALS-25-00469","DOIUrl":"10.7326/ANNALS-25-00469","url":null,"abstract":"<p><strong>Background: </strong>There is limited evidence of the strategies to mitigate burnout among all health care professionals (HCPs).</p><p><strong>Purpose: </strong>To evaluate the effectiveness of all interventions to mitigate burnout among HCPs.</p><p><strong>Data sources: </strong>PubMed and Scopus (up to 14 May 2025).</p><p><strong>Study selection: </strong>Independent study selection (2 people) of randomized controlled trials (RCTs) and cluster RCTs of interventions to mitigate burnout (vs. no active intervention) among HCPs.</p><p><strong>Data extraction: </strong>Independent extraction with validation by second reviewer. Continuous data for burnout outcomes extracted for emotional exhaustion (EE), depersonalization, personal accomplishment (PA), and single-concept burnout measurement. Separate random-effects models were stratified by role.</p><p><strong>Data synthesis: </strong>93 RCTs and 6 cluster RCTs evaluating individual-level interventions were included (9330 participants). Among physicians, professional coaching was probably effective in reducing some aspects of burnout (EE standardized mean difference [SMD], -0.37 [95% CI, -0.62 to -0.13], low certainty; and depersonalization SMD, -0.30 [CI, -0.42 to -0.19], moderate certainty), but mindfulness-based interventions may not be effective (EE SMD, -0.46 [CI, -1.28 to 0.35], very low certainty; depersonalization SMD, -0.09 [CI, -0.30 to 0.12], moderate certainty). However, mindfulness-based interventions may reduce burnout among nurses and midwives (EE SMD, -0.90 [CI,-1.46 to -0.34], low certainty) and among a mixture of HCP roles (EE SMD, -0.40 [-0.65 to -0.16], low certainty; depersonalization SMD, -0.36 [CI, -0.58 to -0.14], low certainty; and PA SMD, 0.48 [CI, 0.29 to 0.67], moderate certainty). Mindfulness-based and professional coaching interventions were generally more than 4 weeks in duration.</p><p><strong>Limitations: </strong>Most trials were unblinded with subjective outcomes. There was substantial heterogeneity among interventions and populations despite stratifying by role.</p><p><strong>Conclusion: </strong>Although mindfulness-based interventions may reduce burnout in nurses and midwives and among a mixture of HCPs, professional coaching probably reduces burnout among physicians, particularly when sustained for more than 4 weeks.</p><p><strong>Primary funding source: </strong>Barts Charity. (PROSPERO: CRD42024552385).</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"51-66"},"PeriodicalIF":15.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145538394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Web Exclusive. Annals Graphic Medicine - "Well, I Did My Own Research…". 医学年鉴- “嗯,我自己做了研究…”
IF 15.2 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 Epub Date: 2025-12-23 DOI: 10.7326/ANNALS-25-04697-GM
Peter Sherman
{"title":"Web Exclusive. Annals Graphic Medicine - \"Well, I Did My Own Research…\".","authors":"Peter Sherman","doi":"10.7326/ANNALS-25-04697-GM","DOIUrl":"10.7326/ANNALS-25-04697-GM","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"e2504697GM"},"PeriodicalIF":15.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145809276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
School-Level Gaps in MMR Coverage as the Fuel for Measles Outbreaks. 麻疹暴发的导火索是学校层面MMR覆盖率的差距。
IF 15.2 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 Epub Date: 2025-10-07 DOI: 10.7326/ANNALS-25-01611
Meagan C Fitzpatrick, Chad R Wells, Abhishek Pandey, Lamia Ayaz, Peter J Hotez, Seyed M Moghadas, Alison P Galvani
{"title":"School-Level Gaps in MMR Coverage as the Fuel for Measles Outbreaks.","authors":"Meagan C Fitzpatrick, Chad R Wells, Abhishek Pandey, Lamia Ayaz, Peter J Hotez, Seyed M Moghadas, Alison P Galvani","doi":"10.7326/ANNALS-25-01611","DOIUrl":"10.7326/ANNALS-25-01611","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"149-152"},"PeriodicalIF":15.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145237783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Massive Amounts of Data: More Publications, Better Science? 海量数据:更多的出版物,更好的科学?
IF 15.2 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 Epub Date: 2025-11-25 DOI: 10.7326/ANNALS-25-03424
Howard Bauchner, Frederick P Rivara
{"title":"Massive Amounts of Data: More Publications, Better Science?","authors":"Howard Bauchner, Frederick P Rivara","doi":"10.7326/ANNALS-25-03424","DOIUrl":"10.7326/ANNALS-25-03424","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"125-126"},"PeriodicalIF":15.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145595797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polymerase Chain Reaction-Confirmed Oropouche Virus Disease in Loreto, Perú: A Case Series From December 2023 Through September 2024. 聚合酶链反应-确认Oropouche病毒病在洛雷托Perú:从2023年12月到2024年9月的病例系列。
IF 15.2 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-01 Epub Date: 2025-11-11 DOI: 10.7326/ANNALS-25-02192
Edgar A Ramírez-García, Nelson Iván Agudelo Higuita, Andrés F Henao-Martínez, Carlos Franco-Paredes, Luis A Marcos, Juan C Celis-Salinas, Cesar Ramal-Asayag, Martín Casapía Morales
{"title":"Polymerase Chain Reaction-Confirmed Oropouche Virus Disease in Loreto, Perú: A Case Series From December 2023 Through September 2024.","authors":"Edgar A Ramírez-García, Nelson Iván Agudelo Higuita, Andrés F Henao-Martínez, Carlos Franco-Paredes, Luis A Marcos, Juan C Celis-Salinas, Cesar Ramal-Asayag, Martín Casapía Morales","doi":"10.7326/ANNALS-25-02192","DOIUrl":"10.7326/ANNALS-25-02192","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"147-149"},"PeriodicalIF":15.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145487476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Internal Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1